CliffBio
small molecule

ZADITOR

KETOTIFEN FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameZADITOR
Active ingredientKETOTIFEN FUMARATE
StrengthEQ 0.025% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalSeptember 2008
Marketing statusOTC

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ZADITOR patent cliff — loss of exclusivity — | CliffBio